Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".

This joint resolution, H.J. Res. 123, directly disapproves and nullifies the rule submitted by the Centers for Medicare & Medicaid Services (CMS) titled "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability." The actual bill text states, "Congress disapproves the rule... and such rule shall have no force or effect." This means the specific changes outlined in the CMS rule, including standardized open enrollment periods, pre-enrollment verification for special enrollment periods, and the prohibition of DACA recipients from enrolling in exchange plans or state Basic Health Programs, will not be implemented. The immediate consequence is the removal of regulatory measures designed to stabilize the ACA marketplace, increasing operational uncertainty for health insurers. The money trail in this scenario is defined by the absence of regulatory stability. The CMS rule aimed to streamline enrollment and reduce fraud, which would have positively impacted insurers' bottom lines by creating a more predictable and healthier risk pool. By nullifying this rule, insurers face higher administrative costs, increased risk from less stringent enrollment verification, and potentially less healthy enrollees. There is no direct appropriation of funds or specific contracts; rather, the impact is on the operational environment and profitability of companies participating in the ACA exchanges. Historically, legislative actions impacting the ACA have led to significant market reactions for health insurers. For example, in 2017, when efforts to repeal and replace the ACA gained momentum, health insurer stocks experienced volatility. While a direct nullification of a specific CMS rule of this nature has not occurred with the same market-wide impact, any action that destabilizes the ACA marketplace has historically led to a negative sentiment for insurers heavily invested in the exchanges. When the Trump administration took actions to reduce ACA enrollment outreach in 2017, companies like Centene ($CNC) saw increased volatility due to their significant exposure to the marketplace, though specific price action is difficult to isolate from broader market trends. Specific winners are non-existent in this scenario, as the nullification removes stabilizing measures. The clear losers are health insurers with substantial exposure to the ACA marketplace. Centene ($CNC) is the largest Medicaid managed care organization and a major participant in the ACA exchanges, making it highly vulnerable to increased market instability and reduced profitability. Molina Healthcare ($MOH) also has a significant presence in the ACA exchanges and will experience similar negative impacts from the removal of these stabilizing regulations. The timeline for this resolution is immediate upon passage; if enacted, the CMS rule would cease to have effect, creating an immediate shift in the regulatory landscape for ACA insurers. This resolution was introduced by Rep. Sykes, Emilia Strong [D-OH-13], a junior member, and has 34 cosponsors. While the number of cosponsors indicates some support, the sponsorship by a junior member suggests it may face an uphill battle, particularly given the policy area of health, which is often highly contentious. However, the direct nature of the nullification means that if it passes, the impact is immediate and substantial.